Kaken Pharmaceutical Co., Ltd. (TYO:4521)
Japan
· Delayed Price · Currency is JPY 4,049.00
-84.00 (-2.03%)
Apr 24, 2025, 3:30 PM JST
Kaken Pharmaceutical Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 23, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Market Capitalization | 153,316 | 130,992 | 138,463 | 147,114 | 166,112 | 195,756 | Upgrade
|
| Market Cap Growth | 34.53% | -5.40% | -5.88% | -11.44% | -15.14% | -2.02% | Upgrade
|
| Enterprise Value | 77,413 | 68,690 | 72,334 | 84,580 | 101,291 | 135,647 | Upgrade
|
| Last Close Price | 4049.00 | 3304.77 | 3385.04 | 3424.40 | 3685.76 | 4142.98 | Upgrade
|
| PE Ratio | 7.47 | 16.32 | 25.45 | 15.41 | 12.39 | 10.11 | Upgrade
|
| Forward PE | 20.91 | 19.39 | 13.57 | 13.10 | 13.02 | 12.05 | Upgrade
|
| PS Ratio | 1.64 | 1.82 | 1.90 | 1.94 | 2.22 | 2.19 | Upgrade
|
| PB Ratio | 0.99 | 0.91 | 1.01 | 1.06 | 1.22 | 1.52 | Upgrade
|
| P/TBV Ratio | 1.04 | 0.96 | 1.07 | 1.14 | 1.23 | 1.53 | Upgrade
|
| P/FCF Ratio | - | 182.95 | 19.06 | 14.21 | 13.39 | 7.74 | Upgrade
|
| P/OCF Ratio | - | 50.83 | 14.96 | 11.03 | 11.55 | 7.13 | Upgrade
|
| EV/Sales Ratio | 0.83 | 0.95 | 0.99 | 1.11 | 1.35 | 1.52 | Upgrade
|
| EV/EBITDA Ratio | - | 5.60 | 6.85 | 4.33 | 5.04 | 4.63 | Upgrade
|
| EV/EBIT Ratio | 2.97 | 7.22 | 9.04 | 4.96 | 5.69 | 5.12 | Upgrade
|
| EV/FCF Ratio | - | 95.94 | 9.96 | 8.17 | 8.16 | 5.36 | Upgrade
|
| Debt / Equity Ratio | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | Upgrade
|
| Debt / EBITDA Ratio | - | 0.31 | 0.36 | 0.20 | 0.19 | 0.13 | Upgrade
|
| Debt / FCF Ratio | - | 5.38 | 0.53 | 0.37 | 0.31 | 0.15 | Upgrade
|
| Asset Turnover | 0.52 | 0.43 | 0.44 | 0.46 | 0.47 | 0.57 | Upgrade
|
| Inventory Turnover | 1.95 | 2.05 | 2.19 | 2.28 | 2.48 | 2.98 | Upgrade
|
| Quick Ratio | 3.75 | 4.68 | 4.49 | 4.98 | 4.60 | 4.39 | Upgrade
|
| Current Ratio | 4.38 | 5.62 | 5.27 | 5.81 | 5.34 | 5.00 | Upgrade
|
| Return on Equity (ROE) | 13.90% | 5.72% | 3.95% | 6.96% | 10.13% | 15.52% | Upgrade
|
| Return on Assets (ROA) | 9.01% | 3.52% | 3.02% | 6.49% | 6.92% | 10.56% | Upgrade
|
| Return on Capital (ROIC) | 10.75% | 4.13% | 3.54% | 7.56% | 8.16% | 12.88% | Upgrade
|
| Return on Capital Employed (ROCE) | 15.90% | 6.20% | 5.50% | 11.70% | 12.50% | 19.50% | Upgrade
|
| Earnings Yield | 13.39% | 6.13% | 3.93% | 6.49% | 8.07% | 9.89% | Upgrade
|
| FCF Yield | - | 0.55% | 5.25% | 7.03% | 7.47% | 12.93% | Upgrade
|
| Dividend Yield | 3.63% | 4.54% | 4.43% | 4.38% | 4.07% | 3.62% | Upgrade
|
| Payout Ratio | - | 70.49% | 103.84% | 59.84% | 43.35% | 30.44% | Upgrade
|
| Buyback Yield / Dilution | -0.62% | -0.44% | 1.07% | 1.59% | 1.41% | 1.84% | Upgrade
|
| Total Shareholder Return | 3.01% | 4.10% | 5.50% | 5.97% | 5.47% | 5.46% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.